ExAblate Blood-Brain Barrier Opening for Treatment of Alzheimer's Disease

Clinical trial NCT03739905 · COMPLETED

Trial details

NCT number: NCT03739905
Sponsor: InSightec
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2018-12-06
Primary completion: 2025-04-09
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.